$33.81
Today
as of Jul 22, 16:52 ET
Last 30 days
Recent Press Releases & News
PAHC: What does Argus have to say about PAHC?
PAHC or LZAGY: Which Is the Better Value Stock Right Now?
Phibro Animal Health (PAHC) Leaves Russell Indexes, Is The Stock A Bargain?
Overview
52-week range
$23
$60
29% of range
Avg surprise (last 3)
+12.1%
Avg reaction (last 2)
+2.9%
100% positive
Latest IV / EM
67%
EM ±15.3% · $35 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 6, 2026 | Mar/2026 | $0.76 | $0.72 | +5.6% | +20.6% | +4.0% | earnings |
| Wed Dec 31, 2025 | Dec 2025 | $0.67 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $0.65 | — | — | — | — | financials |
| Wed Aug 27, 2025 | Jun/2025 | $0.57 | $0.52 | +9.6% | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $0.63 | $0.52 | +21.1% | — | +1.8% | earnings |
| Tue Dec 31, 2024 | Dec 2024 | $0.08 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $0.17 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.21 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $0.03 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.20 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | $258M | $241M | $244M | — | $243M | $207M | $177M | — |
| Gross profit | $126M | $133M | $120M | — | $105M | $102M | $83M | — |
| Operating income | $45M | $50M | $51M | — | $34M | $26M | $18M | — |
| Net income | $24M | $27M | $27M | — | $21M | $3M | $7M | — |
| EPS (diluted) | $0.59 | $0.67 | $0.65 | — | $0.51 | $0.08 | $0.17 | — |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $55M | $55M | $73M | $68M | $60M | $67M | $52M | $71M |
| Inventory | $540M | $517M | $472M | $444M | $448M | $427M | $273M | $266M |
| Total current assets | $894M | $862M | $836M | $811M | $776M | $746M | $571M | $601M |
| Total assets | $1.45B | $1.41B | $1.39B | $1.36B | $1.32B | $1.29B | $966M | $982M |
| Long-term debt | $598M | $604M | $610M | $615M | $619M | $623M | $288M | $282M |
| Total liabilities | $1.08B | $1.07B | $1.07B | $1.08B | $1.05B | $1.04B | $708M | $726M |
| Total equity | $362M | $332M | $312M | $286M | $266M | $247M | $259M | $257M |